Key Market Indicators
New Zealander hormones sales are forecast to reach $20.36 million by 2026, up from $19.25 million in 2021. On average, this is a 1.3% year-on-year growth. Since 1998, the New Zealander market has decreased by 0.4% annually. In 2021, Portugal was ahead in the rankings at $19.25 million. Germany, the United Kingdom and Italy were placed second, third and fourth respectively.
